Non-Viral Gene Therapy 2011
DOI: 10.5772/22166
|View full text |Cite
|
Sign up to set email alerts
|

Toxicity of Polymeric-Based Non-Viral Vector Systems for Pulmonary siRNA Application

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2014
2014
2019
2019

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 118 publications
(131 reference statements)
0
3
0
Order By: Relevance
“…13−15 However, their low transfection efficacy compared to viral vectors and structure-dependent cytotoxicity limit their wide therapeutic applications. 9 Therefore, the search of new and more effective CPs as gene carriers remains topical.…”
Section: ■ Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…13−15 However, their low transfection efficacy compared to viral vectors and structure-dependent cytotoxicity limit their wide therapeutic applications. 9 Therefore, the search of new and more effective CPs as gene carriers remains topical.…”
Section: ■ Introductionmentioning
confidence: 99%
“…CPs have also attracted keen attention because of their lower safety risks and ability to interact with cells effectively. Carefully designed CPs easily form complexes with negatively charged nucleic acids, condensing them into nano-sized structures. However, their low transfection efficacy compared to viral vectors and structure-dependent cytotoxicity limit their wide therapeutic applications . Therefore, the search of new and more effective CPs as gene carriers remains topical.…”
Section: Introductionmentioning
confidence: 99%
“…The major benefit of using such synthetic vectors is their ability to complex and deliver large quantities of nucleic acids of virtually any size, and they are also generally considered to be safer than viral vectors. The therapeutic applications of such nonviral gene delivery systems are still rather limited. The major limitations of synthetic polymers compared to viral-based carriers are their relatively low transfection efficiency and high cytotoxicity, and the latter is the main focus of our work.…”
Section: Introductionmentioning
confidence: 99%